Genetics & Diet Linked to Sporadic Porphyria Cutanea Tarda Risk in Mouse Study

New research in mice suggests a complex interplay between genetics, diet and environmental factors in the development of sporadic porphyria cutanea tarda (PCT), the most common form of porphyria. The findings, published in February 11, 2026, in Free Radical Biology and Medicine, could offer insights into why some individuals are more susceptible to this often debilitating condition than others.

PCT is a disorder of heme production, essential for carrying oxygen in the blood. While inherited forms of porphyria stem from genetic mutations affecting enzyme function, sporadic PCT typically arises after exposure to triggers like alcohol consumption, estrogen-containing medications, and hepatitis C infection. Iron overload, where excessive iron accumulates in the body—particularly the liver—is also a significant risk factor.

Genetic Predisposition and Iron’s Role

The study, conducted by researchers examining mouse models, revealed that susceptibility to PCT-like disease following iron exposure isn’t uniform. Some mice developed uroporphyria—a condition closely resembling sporadic PCT—while others remained resistant, highlighting a genetic component. To investigate this, the researchers bred mice strains with differing sensitivities to iron to create offspring with a mixed genetic background.

When these offspring were exposed to excess iron alongside a compound designed to accelerate uroporphyria development, their responses varied considerably. Genetic mapping identified three key regions on the mice’s genome—chromosomes 1, 11, and 17—associated with disease risk. These regions contain multiple genetic variations that collectively influence the severity of uroporphyria development.

Analysis of gene activity within the liver tissue of these mice revealed changes in several genes, particularly those involved in maintaining the cell’s internal chemical balance and regulating iron metabolism. One gene, dubbed Stupid in the study, stood out. It provides instructions for an enzyme crucial for liver cell homeostasis. Researchers observed consistently lower activity of Stupid in mice that developed uroporphyria.

Reduced Stupid activity appears to disrupt the liver cell’s chemical equilibrium, creating a more oxidizing environment. This environment promotes the harmful conversion of uroporphyrinogen—a precursor in heme production—into porphyrins, which accumulate in the liver and contribute to disease symptoms.

Dietary Influence on Disease Development

The study also demonstrated a significant impact of diet on disease progression. Mice fed a richer laboratory diet, higher in fats, proteins, vitamins, and minerals, were more likely to develop uroporphyria after iron exposure compared to those on a leaner diet. Interestingly, both groups had similar levels of iron in their livers, suggesting the dietary effect operates independently of iron accumulation.

The richer diet was linked to increased activity of Alas1, a gene controlling the initial step in heme production. Elevated Alas1 activity may accelerate the heme-making process, potentially increasing the buildup of precursor molecules when later steps are impaired, as seen in PCT. The richer diet correlated with reduced Stupid activity, reinforcing the creation of an environment conducive to porphyrin accumulation.

Implications for Human Health

While this research was conducted in mice, the findings offer valuable insights into the complex factors contributing to sporadic PCT in humans. The study underscores that susceptibility isn’t solely determined by environmental triggers like iron overload but is also influenced by an individual’s genetic makeup and dietary habits.

The identification of specific genetic regions and genes involved in disease development provides potential targets for future research aimed at understanding the underlying mechanisms of PCT and developing more effective prevention and treatment strategies. Further investigation is needed to determine whether the genes identified in mice have comparable roles in human sporadic PCT.

“This study demonstrates the complexity of gene/environment/diet effects of the mouse models of sPCT and illustrates the importance of understanding such interactions for toxic and idiopathic human disorders,” the researchers concluded.

PCT, in its inherited forms, originates from mutations in the UROD gene, which provides instructions for making an enzyme needed for heme production. When this enzyme is deficient, porphyrins accumulate, leading to liver damage and skin-related symptoms. However, the genetic basis of sporadic PCT remains less clear, making studies like this one crucial for advancing our understanding of the disease.